New collaboration to find vaccine protection for the 'known unknown'
A new collaboration between the The Pirbright Institute and the UK Health Security Agency (UKHSA) has been initiated to support the development of vaccines against a group of lethal viruses.
Researchers will address the threat of outbreaks caused by previously unknown or emerging henipaviruses, akin to the way SARS-CoV-2 emerged to spark the Covid-19 pandemic in 2019.